ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1882

Predictors of a Favorable Outcome in Patients with Fibromyalgia: Results From the 1-Year Follow-up

Dong-Jin Park1, Shin-Seok Lee2, Seong-Ho Kim3, Seong-Su Nah4, Ji Hyun Lee5, Seong-Kyu Kim6, Yeon-Ah Lee7, Seung-Jae Hong7, Hyun-Sook Kim8, Hye-Soon Lee9, Hyoun Ah Kim10, Chung-Il Joung11 and Sang-Hyon Kim12, 1Rheumatology, Chonnam National University Medical School, Gwangju, South Korea, 2Dept of Int Med/Rheumatology, Chonnam National University Medical School, Gwangju, South Korea, 3Department of Internal Medicine,, Inje University Haeundae Paik Hospital, Busan, South Korea, 4Rheumatology, Soonchunhyang University, South Korea, 5Division of Rheumatology, Department of Internal Medicine, Maryknoll Medical Center, Busan, South Korea, 6Catholic University of Daegu School of Medicine, Daegu, South Korea, 7Division of Rheumatology, Department of Internal Medicine, Kyung Hee University, Seoul, South Korea, 8Internal Medicine, Chosun University Hospital, Gwangju, South Korea, 9Department of Rheumatology, Hanyang University Guri Hospital, Guri, South Korea, 10Ajou University Hospital, Suwon, South Korea, 11Department of Internal Medicine, Konyang university hospital, Daejeon, South Korea, 12Division of Rheumatology, Department of Internal Medicine, Keimyung University School of Medicine, Daegu, South Korea

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: fibromyalgia

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Fibromyalgia and Soft Tissue Disorders

Session Type: Abstract Submissions (ACR)

Background/Purpose: To determine the outcomes in Korean patients with fibromyalgia (FM) and identify the prognostic factors associated with improvement at 1-year follow-up.

Methods: Forty-eight patients with FM were enrolled and examined every 3 months for 1-year. We interviewed these patients using a structured questionnaire that included sociodemograhpic data, current or past FM symptoms, and current use of relevant medications at the time of enrollment. Tender point counts and scores were assessed by thumb palpation. Patients were asked to complete a Korean version of the Fibromyalgia Impact Questionnaire (FIQ), the Brief Fatigue Inventory, the SF-36, the Beck Depression Inventory, the State-Trait Anxiety Inventory, the Self-Efficacy Scale, and the Social Support Scale. During follow-up, tender points, FIQ, and current use of relevant medications were recorded during 1 year follow-up period.

Results: Of the 48 patients, 32 (66.7%) had improved FIQ scores 1 year after enrollment. The improved patients had higher baseline FIQ scores (68.4±13.9 vs 48.4±20.8, p=0.001) and higher Trait Anxiety Inventory scores (55.8±10.9 vs 11.5±11.5, p=0.022). The patients treated with pregabalin which was added during the follow-up period were more likely to be improved after 1-year (71.9 % vs 37.5 %, p=0.031). In multivariate logistic regression analyses, the additional use of pregabalin and higher Trait Anxiety Inventory scores at baseline were the predictor of improvement (p=0.026 and p=0.043) and this statistical significance persisted after adjustment for age, gender, and disease duration (p=0.016 and p=0.037).

Conclusion: Two-thirds of the Korean FM patients experienced some clinical improvement by 1-year after enrollment. The use of pregabalin and anxiety were shown to be important predictors of improved FM. Interventions, particularly medications, may be associated with good outcome in a significant number of these patients.


Disclosure:

D. J. Park,
None;

S. S. Lee,
None;

S. H. Kim,
None;

S. S. Nah,
None;

J. H. Lee,
None;

S. K. Kim,
None;

Y. A. Lee,
None;

S. J. Hong,
None;

H. S. Kim,
None;

H. S. Lee,
None;

H. A. Kim,
None;

C. I. Joung,
None;

S. H. Kim,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/predictors-of-a-favorable-outcome-in-patients-with-fibromyalgia-results-from-the-1-year-follow-up/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology